Investigating Psychedelic Tryptamines: Extraction and Quantification from Psilocybe Mushrooms

Authors

  • Beatriz P. Senra Associate Laboratory i4HB - Institute for Health and Bioeconomy, University Institute of Health Sciences - CESPU, 4585-116 Gandra, Portugal. UCIBIO - Applied Molecular Biosciences Unit, Translational Toxicology Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), 4585-116 Gandra, Portugal. Department of Public Health and Forensic Sciences, and Medical Education, Faculty of Medicine, University of Porto, Porto, Portugal.
  • Ricardo Jorge Dinis-Oliveira Associate Laboratory i4HB - Institute for Health and Bioeconomy, University Institute of Health Sciences - CESPU, 4585-116 Gandra, Portugal. UCIBIO - Applied Molecular Biosciences Unit, Translational Toxicology Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), 4585-116 Gandra, Portugal. Department of Public Health and Forensic Sciences, and Medical Education, Faculty of Medicine, University of Porto, Porto, Portugal. FOREN—Forensic Science Experts, 1400-136 Lisbon, Portugal. https://orcid.org/0000-0001-7430-6297
  • Carlos J. A. Ribeiro Associate Laboratory i4HB - Institute for Health and Bioeconomy, University Institute of Health Sciences - CESPU, 4585-116 Gandra, Portugal. UCIBIO - Applied Molecular Biosciences Unit, Translational Toxicology Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), 4585-116 Gandra, Portugal. Avextra Portugal SA, 1070-060 Lisboa, Portugal

DOI:

https://doi.org/10.48797/sl.2026.498

Keywords:

Poster Communication

Abstract

Background: Psilocybe cubensis mushrooms contain the tryptamines psilocybin and psilocin, which are recognized for their therapeutic potential in mental health [1]. Additionally, due to their psychedelic effects, these mushrooms are also used for religious and recreational purposes. The increasing use of these tryptamines and other psychoactive substances has led to regulatory measures, particularly Portuguese Decree-Law No. 15/93 of January 22, which aims to regulate the production, distribution, possession, and consumption of these substances. Psilocybin is generally more prevalent, with concentrations in dried mushrooms ranging from 0.5% to 1.5% [2]. Objective: The goal was to develop an efficient method for extracting and quantifying psilocin and psilocybin, as well as a fast and simple technique for identifying tryptamines. Methods: The mushrooms were finely pulverized using a cold porcelain mortar and pestle and extracted twice through kinetic maceration on a magnetic stirrer plate, with cold methanol containing 10% water serving as the extraction solvent (0.1 mL/mg of mushroom). An Agilent 1260 Infinity II HPLC-DAD system with a Poroshell 120 EC-C18 3.0 x 150 mm, 2.7 µm column protected with a Poroshell 120 EC-C18 3.0 mm, 2.7 µm guard column was used for psilocin and psilocybin quantification [3]. Results: In order to optimize the extraction method, various parameters were taken into account, including solvent, extraction time, the number of extractions, agitation rate, temperature, and the solvent-to-dry material ratio. The concentrations of psilocybin and psilocin in the mushroom were found to be 1.98% and 0.10%, respectively. A Thin Layer Chromatography (TLC) method was developed for the rapid identification of psilocybin and psilocin, utilizing Ehrlich's reagent as the detection solution. Conclusions: An optimized extraction protocol was successfully established to maximize the recovery of target compounds. Additionally, a fast TLC identification method was developed for application in forensic sciences.

References

1.Kinderlehrer, D. Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity. Neuropsychiatr Dis Treat 2025, 21, 141–155, doi:10.2147/NDT.S500337.

2.Luz, M.A. et al. Chemical Composition and Biological Activities of Psilocybe Mushrooms: Gaps and Perspectives. Pharmaceuticals 2025, 18, 989, doi:10.3390/ph18070989.

3.Senra, B.P. et al. Development and Validation of an HPLC-DAD Analytical Method for Psilocybin and Psilocin. Sci Lett 2025, 1 (Sup 1). https://doi.org/10.48797/sl.2025.330.

Downloads

Published

2026-05-05

How to Cite

Senra, B. . P., Dinis-Oliveira, R. J., & Ribeiro, C. J. A. (2026). Investigating Psychedelic Tryptamines: Extraction and Quantification from Psilocybe Mushrooms. Scientific Letters, 1(Sup 1). https://doi.org/10.48797/sl.2026.498

Issue

Section

Posters

Most read articles by the same author(s)

<< < 1 2 3 4 

Similar Articles

1 2 3 > >> 

You may also start an advanced similarity search for this article.